These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 22786810)

  • 21. Synthesis of novel HIV protease inhibitors (PI) with activity against PI-resistant virus.
    Raghavan S; Lu Z; Beeson T; Chapman KT; Schleif WA; Olsen DB; Stahlhut M; Rutkowski CA; Gabryelski L; Emini E; Tata JR
    Bioorg Med Chem Lett; 2007 Oct; 17(19):5432-6. PubMed ID: 17692518
    [TBL] [Abstract][Full Text] [Related]  

  • 22. On the role of the R configuration of the reaction-intermediate isostere in HIV-1 protease-inhibitor binding: X-ray structure at 2.0 A resolution.
    Dusková J; Dohnálek J; Skálová T; Petroková H; Vondrácková E; Hradílek M; Konvalinka J; Soucek M; Brynda J; Fábry M; Sedlácek J; Hasek J
    Acta Crystallogr D Biol Crystallogr; 2006 May; 62(Pt 5):489-97. PubMed ID: 16627941
    [TBL] [Abstract][Full Text] [Related]  

  • 23. An ethylenamine inhibitor binds tightly to both wild type and mutant HIV-1 proteases. Structure and energy study.
    Skálová T; Hasek J; Dohnálek J; Petroková H; Buchtelová E; Dusková J; Soucek M; Majer P; Uhlíková T; Konvalinka J
    J Med Chem; 2003 Apr; 46(9):1636-44. PubMed ID: 12699382
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Phosphoramidate protides of 2',3'-dideoxy-3'-fluoroadenosine and related nucleosides with potent activity against HIV and HBV.
    Gudmundsson KS; Daluge SM; Johnson LC; Jansen R; Hazen R; Condreay LD; McGuigan C
    Nucleosides Nucleotides Nucleic Acids; 2003 Oct; 22(10):1953-61. PubMed ID: 14609234
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Alpha-ketoamide Phe-Pro isostere as a new core structure for the inhibition of HIV protease.
    Munoz B; Giam CZ; Wong CH
    Bioorg Med Chem; 1994 Oct; 2(10):1085-90. PubMed ID: 7773625
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synthesis and biological evaluation of phosphoramidate prodrugs of two analogues of 2-deoxy-d-ribose-1-phosphate directed to the discovery of two carbasugars as new potential anti-HIV leads.
    Hamon N; Slusarczyk M; Serpi M; Balzarini J; McGuigan C
    Bioorg Med Chem; 2015 Feb; 23(4):829-38. PubMed ID: 25616343
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Aryloxy phosphoramidate triesters: a technology for delivering monophosphorylated nucleosides and sugars into cells.
    Mehellou Y; Balzarini J; McGuigan C
    ChemMedChem; 2009 Nov; 4(11):1779-91. PubMed ID: 19760699
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Solid-phase synthesis of HTLV-1 protease inhibitors containing hydroxyethylamine dipeptide isostere.
    Akaji K; Teruya K; Aimoto S
    J Org Chem; 2003 Jun; 68(12):4755-63. PubMed ID: 12790579
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cyclic urea amides: HIV-1 protease inhibitors with low nanomolar potency against both wild type and protease inhibitor resistant mutants of HIV.
    Jadhav PK; Ala P; Woerner FJ; Chang CH; Garber SS; Anton ED; Bacheler LT
    J Med Chem; 1997 Jan; 40(2):181-91. PubMed ID: 9003516
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Design and synthesis of novel P2 substituents in diol-based HIV protease inhibitors.
    Adrian Meredith J; Wallberg H; Vrang L; Oscarson S; Parkes K; Hallberg A; Samuelsson B
    Eur J Med Chem; 2010 Jan; 45(1):160-70. PubMed ID: 19926360
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Structure-based design: synthesis and biological evaluation of a series of novel cycloamide-derived HIV-1 protease inhibitors.
    Ghosh AK; Swanson LM; Cho H; Leshchenko S; Hussain KA; Kay S; Walters DE; Koh Y; Mitsuya H
    J Med Chem; 2005 May; 48(10):3576-85. PubMed ID: 15887965
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Aryl H-phosphonates. 19. New anti-HIV pronucleotide phosphoramidate diesters containing amino- and hydroxypyridine auxiliaries.
    Romanowska J; Kolodziej K; Sobkowski M; Rachwalak M; Jakubowski T; Golebiewska J; Kraszewski A; Boryski J; Dabrowska A; Stawinski J
    Eur J Med Chem; 2019 Feb; 164():47-58. PubMed ID: 30590257
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Three-dimensional QSAR of human immunodeficiency virus (I) protease inhibitors. 1. A CoMFA study employing experimentally-determined alignment rules.
    Waller CL; Oprea TI; Giolitti A; Marshall GR
    J Med Chem; 1993 Dec; 36(26):4152-60. PubMed ID: 8277496
    [TBL] [Abstract][Full Text] [Related]  

  • 34. P1-substituted symmetry-based human immunodeficiency virus protease inhibitors with potent antiviral activity against drug-resistant viruses.
    Degoey DA; Grampovnik DJ; Chen HJ; Flosi WJ; Klein LL; Dekhtyar T; Stoll V; Mamo M; Molla A; Kempf DJ
    J Med Chem; 2011 Oct; 54(20):7094-104. PubMed ID: 21899332
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Novel P1 chain-extended HIV protease inhibitors possessing potent anti-HIV activity and remarkable inverse antiviral resistance profiles.
    Miller JF; Brieger M; Furfine ES; Hazen RJ; Kaldor I; Reynolds D; Sherrill RG; Spaltenstein A
    Bioorg Med Chem Lett; 2005 Aug; 15(15):3496-500. PubMed ID: 15990305
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The novel phosphoramidate derivatives of NSAID 3-hydroxypropylamides: synthesis, cytostatic and antiviral activity evaluations.
    Wittine K; Benci K; Rajić Z; Zorc B; Kralj M; Marjanović M; Pavelić K; De Clercq E; Andrei G; Snoeck R; Balzarini J; Mintas M
    Eur J Med Chem; 2009 Jan; 44(1):143-51. PubMed ID: 18485540
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hydroxyethylamine derivatives as HIV-1 protease inhibitors: a predictive QSAR modelling study based on Monte Carlo optimization.
    Bhargava S; Adhikari N; Amin SA; Das K; Gayen S; Jha T
    SAR QSAR Environ Res; 2017 Dec; 28(12):973-990. PubMed ID: 29072112
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Orally bioavailable highly potent HIV protease inhibitors against PI-resistant virus.
    Lu Z; Bohn J; Rano T; Rutkowski CA; Simcoe AL; Olsen DB; Schleif WA; Carella A; Gabryelski L; Jin L; Lin JH; Emini E; Chapman K; Tata JR
    Bioorg Med Chem Lett; 2005 Dec; 15(23):5311-4. PubMed ID: 16203148
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Aminoethylenes: a tetrahedral intermediate isostere yielding potent inhibitors of the aspartyl protease BACE-1.
    Yang W; Lu W; Lu Y; Zhong M; Sun J; Thomas AE; Wilkinson JM; Fucini RV; Lam M; Randal M; Shi XP; Jacobs JW; McDowell RS; Gordon EM; Ballinger MD
    J Med Chem; 2006 Feb; 49(3):839-42. PubMed ID: 16451048
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Structure-activity relationship study of hydroxyethylamine isostere and P1' site structure of peptide mimetic BACE1 inhibitors.
    Kobayashi K; Otani T; Ijiri S; Kawasaki Y; Matsubara H; Miyagi T; Kitajima T; Iseki R; Ishizawa K; Shindo N; Okawa K; Ueda K; Ando S; Kawakita M; Hattori Y; Akaji K
    Bioorg Med Chem; 2021 Nov; 50():116459. PubMed ID: 34700240
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.